Literature DB >> 17600932

The burden of cervical cancer in south-east Europe at the beginning of the 21st century.

Marc Arbyn1, Maja Primic-Zakelj, Amidu O Raifu, Magdalena Grce, Evangelos Paraskevaidis, Emanuel Diakomanolis, Vesna Kesić, Florian A Nicula, Ofelia Suteu, Lawrence von Karsa.   

Abstract

The situation of cervical cancer prevention in South-East Europe is hardly documented, in spite of the fact that it encloses the most affected countries of Europe. We estimated the number of cases of cervical cancer, the number of deaths from this malignancy and the corresponding rates for 11 countries located in South-East Europe, in the period 2002-2004. Each year, approximately 9,000 women develop cervical cancer and about 4,600 die from the disease in this subcontinent. The most affected country is Romania with almost 3,500 cases and more than 2,000 deaths per year High world-age standardised mortality rates (> 7.5 [expressed per 100,000 women-years]) are observed in 7 countries: FYROM (7.6), Moldova (7.8), Bulgaria (8.0), Bosnia & Herzegovina (8.0), Albania (9.8), Serbia & Montenegro (10.1) and Romania (13.0). A matter of concern is the increasing mortality rate, in younger women, in the countries with the highest burden of cervical cancer. Thus, appropriate cervical cancer prevention programmes should be set up without delay in this part of Europe.

Entities:  

Mesh:

Year:  2007        PMID: 17600932

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  7 in total

Review 1.  Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.

Authors:  Maria Kyrgiou; Ilkka E J Kalliala; Anita Mitra; Christina Fotopoulou; Sadaf Ghaem-Maghami; Pierre Pl Martin-Hirsch; Margaret Cruickshank; Marc Arbyn; Evangelos Paraskevaidis
Journal:  Cochrane Database Syst Rev       Date:  2017-01-26

2.  Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study.

Authors:  Anastasiya Muntyanu; Vladimir Nechaev; Elena Pastukhova; James Logan; Elham Rahme; Elena Netchiporouk; Andrei Zubarev; Ivan V Litvinov
Journal:  Lancet Reg Health Eur       Date:  2022-06-30

3.  Young women's constructions of the HPV vaccine: a cross-cultural, qualitative study in Scotland, Spain, Serbia and Bulgaria.

Authors:  Carol Gray Brunton; Ingeborg Farver; Moritz Jäger; Anita Lenneis; Kadi Parve; Dina Patarcic; Dafina Petrova; Rhona Hogg; Catriona Kennedy; Rocio Garcia-Retamero; Irina Todorova
Journal:  Int J Behav Med       Date:  2014-02

Review 4.  Worldwide impact of the human papillomavirus vaccine.

Authors:  Amy A Hakim; Tri A Dinh
Journal:  Curr Treat Options Oncol       Date:  2009-04-23

5.  HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania.

Authors:  Ramona Gabriela Ursu; Mircea Onofriescu; Dragoş Nemescu; Luminiţa-Smaranda Iancu
Journal:  Virol J       Date:  2011-12-22       Impact factor: 4.099

6.  Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy.

Authors:  Maria Lina Tornesello; Paolo Giorgi Rossi; Luigi Buonaguro; Franco Maria Buonaguro
Journal:  Front Oncol       Date:  2014-02-20       Impact factor: 6.244

7.  Cancer incidence and mortality in Serbia 1999-2009.

Authors:  Jovan Mihajlović; Petros Pechlivanoglou; Marica Miladinov-Mikov; Snežana Zivković; Maarten J Postma
Journal:  BMC Cancer       Date:  2013-01-15       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.